Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome

Journal of Human Hypertension

Volumn 27, Issue 1, 2013, Pages 51-55

  Norcliffe Kaufmann, L ^a   Axelrod, F B ^a   Kaufmann, H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

afferent baroreflex failure; blood pressure instability; familial dysautonomia; renal failure

Indexed keywords

CREATININE; FLUDROCORTISONE;

ADULT; ARTICLE; BLOOD PRESSURE VARIABILITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DYSAUTONOMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; HYDRONEPHROSIS; HYPERTENSION; HYPOTENSION; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY MALFORMATION; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

ADULT; BLOOD PRESSURE; DISEASE PROGRESSION; DYSAUTONOMIA, FAMILIAL; FEMALE; FLUDROCORTISONE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84870831824     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2011.107     Document Type: Article

References (29)

1. Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001; 68(3): 598-605.
2. Norcliffe-Kaufmann LJ, Axelrod F, Kaufmann H. Afferent baroreflex failure in familial dysautonomia. Neurology 2010; 75(21): 1904-1911.
3. Pearson J, Gallo G, Gluck M, Axelrod F. Renal disease in familial dysautonomia. Kidney Int 1980; 17(1): 102-112.
4. Elkayam L, Matalon A, Tseng CH, Axelrod F. Prevalence and severity of renal disease in familial dysautonomia. Am J Kidney Dis 2006; 48(5): 780-786.
5. Ratcliffe PJ, Moonen CT, Holloway PA, Ledingham JG, Radda GK. Acute renal failure in hemorrhagic hypotension: cellular energetics and renal function. Kidney Int 1986; 30(3): 355-360.
6. Dobyan DC, Nagle RB, Bulger RE. Acute tubular necrosis in the rat kidney following sustained hypotension: physiologic and morphologic observations. Lab Invest 1977; 37(4): 411-422.
7. Durakovic Z. Does arterial hypotension due to cardiogenic shock in older patients lead to functional oliguria or to acute renal failure? Korean J Intern Med 1997; 12(1): 39-44.
8. Axelrod FB. Familial dysautonomia: a review of the current pharmacological treatments. Expert Opin Pharmacother 2005; 6(4): 561-567.
9. Axelrod FB, Goldberg JD, Rolnitzky L, Mull J, Mann SP, Gold von Simson G et al. Fludrocortisone in patients with familial dysautonomia-assessing effect on clinical parameters and gene expression. Clin Auton Res 2005; 15(4): 284-291.
10. Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A et al. Strict bloodpressure control and progression of renal failure in children. N Engl J Med 2009; 361(17): 1639-1650.
11. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375(9718): 938-948.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16(1): 31-41.
13. Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985; 106(3): 522-526.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6): 461-470.
15. Weizer AZ, Silverstein AD, Auge BK, Delvecchio FC, Raj G, Albala DM et al. Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol 2003; 170(5): 1722-1726.
16. Kupferman JC, Druschel CM, Kupchik GS. Increased prevalence of renal and urinary tract anomalies in children with Down syndrome. Pediatrics 2009; 124(4): e615-e621.
17. Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010; 25(10): 2107-2113.
18. Mezey E, Parmalee A, Szalayova I, Gill SP, Cuajungco MP, Leyne M et al. Of splice and men: what does the distribution of IKAP mRNA in the rat tell us about the pathogenesis of familial dysautonomia? Brain Res 2003; 983(1-2): 209-214.
19. Norcliffe-Kaufmann L, Axelrod F, Kaufmann H. Afferent baroreflex failure in familial dysautonomia. Neurology 2010; 75(21): 1904-1911.
20. Hurtado R, Bub G, Herzlinger D. The pelvis-kidney junction contains HCN3, a hyperpolarization-activated cation channel that triggers ureter peristalsis. Kidney Int 2010; 77(6): 500-508.
21. Tozawa M, Iseki K, Yoshi S, Fukiyama K. Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease. Nephrol Dial Transplant 1999; 14(8): 1976-1981.
22. Shan ZZ, Dai SM, Su DF. Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats. J Cardiovasc Pharmacol 2001; 38(3): 427-437.
23. Zar T, Peixoto AJ. Paroxysmal hypertension due to baroreflex failure. Kidney Int 2008; 74(1): 126-131.
24. Saeki T, Suzuki K, Yamazaki H, Miyamura S, Koike H, Morishita H et al. Four cases of pheochromocytoma in patients with end-stage renal disease. Intern Med 2003; 42(10): 1011-1015.
25. Yver L, Jaulin JP, Nanhuck H, Rivet P. Pheochromocytoma in a long-term hemodialysis patient. Am J Kidney Dis 1991; 18(2): 276-277.
26. Rekhtman Y, Bomback AS, Nash MA, Cohen SD, Matalon A, Jan DM et al. Renal transplantation in familial dysautonomia: report of two cases and review of the literature. Clin J Am Soc Nephrol 2010; 5(9): 1676-1680.
27. Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 2000; 355(9205): 725-726.
28. Hall CE, Hall O. Cardiac and renal lesions due to fludrocortisone and factors influencing their development. Tex Rep Biol Med 1961; 19: 774-784.
29. Shibao C, Gamboa A, Diedrich A, Biaggioni I. Management of hypertension in the setting of autonomic failure: a pathophysiological approach. Hypertension 2005; 45(4): 469-476.